系统治疗对特应性皮炎患者皮肤细菌组的影响:一项前瞻性初步研究
本研究纳入60例特应性皮炎患者,比较JAK抑制剂、度普利尤单抗、环孢素A和外用糖皮质激素对疾病严重程度及皮肤细菌组的影响。治疗3个月后所有组病情均显著改善,但仅度普利尤单抗显著降低血清IgE并几乎完全清除金黄色葡萄球菌。靶向2型炎症的药物使皮肤细菌组趋于健康平衡,而传统抗炎治疗对微生物组成影响甚微。
要点
- 度普利尤单抗可显著降低血清IgE并几乎完全清除金黄色葡萄球菌。
- 金黄色葡萄球菌相对丰度与疾病严重程度相关。
- JAK抑制剂和度普利尤单抗降低葡萄球菌属与棒状杆菌属、皮肤杆菌属的比值。
核心结论
- 靶向2型炎症的药物可改变皮肤细菌组趋向健康平衡,传统抗炎治疗对微生物组成影响极小。
研究设计与样本
- 前瞻性初步研究,纳入60例特应性皮炎患者,比较JAK抑制剂、度普利尤单抗、环孢素A和外用糖皮质激素四类治疗。
- 在治疗前及治疗后3个月和6个月采集样本,分析细菌组多样性和组成。
主要发现
- 所有治疗组在3个月后疾病严重程度均显著改善。
- 仅度普利尤单抗组血清IgE水平显著降低且金黄色葡萄球菌几乎完全清除。
- 金黄色葡萄球菌相对丰度与疾病严重程度相关,且度普利尤单抗组显著低于环孢素A或外用糖皮质激素组。
- 总体细菌组α多样性未变,但JAK抑制剂和度普利尤单抗治疗后葡萄球菌属与棒状杆菌属、皮肤杆菌属的比值显著下降,而环孢素A和外用糖皮质激素组保持稳定。
临床怎么用
- 对于特应性皮炎患者,度普利尤单抗可能通过清除金黄色葡萄球菌和降低IgE带来额外微生物组获益。
- JAK抑制剂也可改善皮肤细菌组平衡,而环孢素A和外用糖皮质激素对微生物组成影响有限。
局限性
- 本研究为初步研究,样本量有限,需更大规模研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Atopic dermatitis is a complex disease that requires treatments addressing skin barrier disruption, inflammation, and microbial imbalance. In this study, we aimed to investigate the effects of 4 different therapies on clinical outcomes and skin bacteriome in patients with atopic dermatitis, namely: Jak inhibitors, dupilumab, cyclosporine A, and topical corticosteroids (intermittently used methylprednisolone aceponate). Samples from 60 patients were collected before treatment and after 3 and 6 months, and their bacteriome diversity and composition were analyzed. All treatment groups showed significant improvement in disease severity after 3 months; however, only dupilumab resulted in a marked reduction in serum IgE levels and an almost complete depletion of Staphylococcus aureus. The relative abundance of this bacterium correlated with disease severity and remained significantly lower in patients receiving dupilumab than in those treated with cyclosporine A or topical corticosteroids. Although overall bacteriome alpha diversity remained unchanged, the ratio of Staphylococcus to Corynebacterium and Cutibacterium decreased significantly after Jak inhibitors as well as dupilumab treatment but remained stable with cyclosporine A and topical corticosteroids. These results indicate that addressing type 2 inflammation by targeted drugs alters the skin bacteriome toward a healthy balance, whereas traditional anti-inflammatory treatments have minimal impact on microbial composition.
引用
- Thomova T, Jedlickova H, Bohm J, et al. Effect of Systemic Therapies on Skin Bacteriome in Patients with Atopic Dermatitis: A Pilot Prospective Study. J Invest Dermatol. 2025. PMID: 40738245. doi:10.1016/j.jid.2025.07.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。